Literature DB >> 24560042

Statins for millions more?

.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24560042     DOI: 10.1016/S0140-6736(14)60240-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Assessing, communicating, and managing risk in general practice.

Authors:  Lyndal Trevena
Journal:  Br J Gen Pract       Date:  2014-04       Impact factor: 5.386

2.  Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis.

Authors:  Peter Ueda; Thomas Wai-Chun Lung; Philip Clarke; Goodarz Danaei
Journal:  Br J Gen Pract       Date:  2017-07-31       Impact factor: 5.386

Review 3.  Current guidelines on prevention with a focus on dyslipidemias.

Authors:  Ian M Graham; Alberico L Catapano; Nathan D Wong
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

Review 4.  Management of Dyslipidemias in Europe and the USA: Same Evidence, Different Conclusions? Can We Find Common Ground?

Authors:  Ian M Graham; Alberico L Catapano
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

Review 5.  Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.

Authors:  Albert Selva-O'Callaghan; Marcelo Alvarado-Cardenas; Iago Pinal-Fernández; Ernesto Trallero-Araguás; José Cesar Milisenda; María Ángeles Martínez; Ana Marín; Moisés Labrador-Horrillo; Cándido Juárez; Josep María Grau-Junyent
Journal:  Expert Rev Clin Immunol       Date:  2018-02-23       Impact factor: 4.473

6.  The Impact of Health Literacy-Sensitive Design and Heart Age in a Cardiovascular Disease Prevention Decision Aid: Randomized Controlled Trial and End-User Testing.

Authors:  Carissa Bonner; Carys Batcup; Julie Ayre; Erin Cvejic; Lyndal Trevena; Kirsten McCaffery; Jenny Doust
Journal:  JMIR Cardio       Date:  2022-04-15

7.  Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings: Evidence from 5 Peruvian Sites.

Authors:  Juan Carlos Bazo-Alvarez; Renato Quispe; Frank Peralta; Julio A Poterico; Giancarlo A Valle; Melissa Burroughs; Timesh Pillay; Robert H Gilman; William Checkley; Germán Malaga; Liam Smeeth; Antonio Bernabé-Ortiz; J Jaime Miranda
Journal:  Crit Pathw Cardiol       Date:  2015-06

8.  Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.

Authors:  Jelena Pavlović; Philip Greenland; Jaap W Deckers; Maryam Kavousi; Albert Hofman; M Arfan Ikram; Oscar H Franco; Maarten Jg Leening
Journal:  Eur J Prev Cardiol       Date:  2017-11-24       Impact factor: 7.804

Review 9.  The use of expensive technologies instead of simple, sound and effective lifestyle interventions: a perpetual delusion.

Authors:  Silvia Carlos; Jokin de Irala; Matt Hanley; Miguel Ángel Martínez-González
Journal:  J Epidemiol Community Health       Date:  2014-06-24       Impact factor: 3.710

10.  Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review.

Authors:  Fanny Villoz; Christina Lyko; Cinzia Del Giovane; Nicolas Rodondi; Manuel R Blum
Journal:  BMJ Open       Date:  2021-08-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.